» Articles » PMID: 26925839

Osteoblast Malfunction Caused by Cell Stress Response to Procollagen Misfolding in α2(I)-G610C Mouse Model of Osteogenesis Imperfecta

Overview
Date 2016 Mar 2
PMID 26925839
Citations 51
Authors
Affiliations
Soon will be listed here.
Abstract

Glycine (Gly) substitutions in collagen Gly-X-Y repeats disrupt folding of type I procollagen triple helix and cause severe bone fragility and malformations (osteogenesis imperfecta [OI]). However, these mutations do not elicit the expected endoplasmic reticulum (ER) stress response, in contrast to other protein-folding diseases. Thus, it has remained unclear whether cell stress and osteoblast malfunction contribute to the bone pathology caused by Gly substitutions. Here we used a mouse with a Gly610 to cysteine (Cys) substitution in the procollagen α2(I) chain to show that misfolded procollagen accumulation in the ER leads to an unusual form of cell stress, which is neither a conventional unfolded protein response (UPR) nor ER overload. Despite pronounced ER dilation, there is no upregulation of binding immunoglobulin protein (BIP) expected in the UPR and no activation of NF-κB signaling expected in the ER overload. Altered expression of ER chaperones αB crystalline and HSP47, phosphorylation of EIF2α, activation of autophagy, upregulation of general stress response protein CHOP, and osteoblast malfunction reveal some other adaptive response to the ER disruption. We show how this response alters differentiation and function of osteoblasts in culture and in vivo. We demonstrate that bone matrix deposition by cultured osteoblasts is rescued by activation of misfolded procollagen autophagy, suggesting a new therapeutic strategy for OI. © 2016 American Society for Bone and Mineral Research.

Citing Articles

Pleiotropic effects of a recessive Col1a2 mutation occurring in a mouse model of severe osteogenesis imperfecta.

Corcelli M, Sagar R, Petzendorfer E, Hasan M, van Dijk F, David A PLoS One. 2025; 20(2):e0309801.

PMID: 39908220 PMC: 11798436. DOI: 10.1371/journal.pone.0309801.


Human cartilage model of the precocious osteoarthritis-inducing p.Arg719Cys reveals pathology-driving matrix defects and a failure of the ER proteostasis network to recognize the defective procollagen-II.

Yammine K, Abularach S, Xiong M, Kim S, Bikovtseva A, Butty V bioRxiv. 2024; .

PMID: 39574595 PMC: 11580999. DOI: 10.1101/2024.11.07.622468.


ER procollagen storage defect without coupled unfolded protein response drives precocious arthritis.

Yammine K, Abularach S, Kim S, Bikovtseva A, Lilianty J, Butty V Life Sci Alliance. 2024; 7(9).

PMID: 38981683 PMC: 11234256. DOI: 10.26508/lsa.202402842.


The double whammy of ER-retention and dominant-negative effects in numerous autosomal dominant diseases: significance in disease mechanisms and therapy.

Gariballa N, Mohamed F, Badawi S, Ali B J Biomed Sci. 2024; 31(1):64.

PMID: 38937821 PMC: 11210014. DOI: 10.1186/s12929-024-01054-1.


RNA-based bone histomorphometry: method and its application to explaining postpubertal bone gain in a G610C mouse model of osteogenesis imperfecta.

Makareeva E, Sousa M, Kent T, de Castro L, Collins M, Leikin S J Bone Miner Res. 2024; 39(2):177-189.

PMID: 38477760 PMC: 11207954. DOI: 10.1093/jbmr/zjad004.


References
1.
Klionsky D, Abeliovich H, Agostinis P, Agrawal D, Aliev G, Askew D . Guidelines for the use and interpretation of assays for monitoring autophagy in higher eukaryotes. Autophagy. 2008; 4(2):151-75. PMC: 2654259. DOI: 10.4161/auto.5338. View

2.
Ishida Y, Yamamoto A, Kitamura A, Lamande S, Yoshimori T, Bateman J . Autophagic elimination of misfolded procollagen aggregates in the endoplasmic reticulum as a means of cell protection. Mol Biol Cell. 2009; 20(11):2744-54. PMC: 2688553. DOI: 10.1091/mbc.e08-11-1092. View

3.
Bakker A, Klein-Nulend J . Osteoblast isolation from murine calvaria and long bones. Methods Mol Biol. 2011; 816:19-29. DOI: 10.1007/978-1-61779-415-5_2. View

4.
Wang Y, Liu Y, Maye P, Rowe D . Examination of mineralized nodule formation in living osteoblastic cultures using fluorescent dyes. Biotechnol Prog. 2006; 22(6):1697-701. PMC: 2538552. DOI: 10.1021/bp060274b. View

5.
Morike M, Windsheimer E, Brenner R, Nerlich A, Bushart G, TELLER W . Effects of transforming growth factor beta on cells derived from bone and callus of patients with osteogenesis imperfecta. J Orthop Res. 1993; 11(4):564-72. DOI: 10.1002/jor.1100110411. View